Lataa...
Xanthine oxidoreductase in cancer: more than a differentiation marker
Human xanthine oxidoreductase (XOR) catalyzes the last two steps of purine catabolism and is present in two interconvertible forms, which may utilize O(2) or NAD (+) as electron acceptors. In addition to uric acid, XOR products may comprise reactive oxygen and nitrogen species that have many biologi...
Tallennettuna:
| Julkaisussa: | Cancer Med |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4799950/ https://ncbi.nlm.nih.gov/pubmed/26687331 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.601 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|